A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction.
about
Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein MFormation of methionine sulfoxide during glycoxidation and lipoxidation of ribonuclease A.The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor deltaAcute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males.Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetesPathological aspects of lipid peroxidation.Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicityTreatment approaches for diabetes and dyslipidemiaReduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathwayMatrix-embedded endothelial cells are protected from the uremic milieuReduced beta 2 glycoprotein I improve diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathwayXiaokening stimulates endothelial nitric oxide release in diabetic rats.Continuous subcutaneous insulin infusion in patients with type 2 diabetes: a cohort study to establish the relationship between glucose control and plasma oxidized low density lipoproteinN-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.Disparate effects of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid in vascular endothelial and smooth muscle cells and in cardiomyocytes.The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients.Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity.The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes.The role of dyslipidemia in diabetic retinopathy.Involvement of CaSR in hyperglycemia-induced macroangiopathy and related mechanism.Apoptosis induction by oxidized glycated LDL in human retinal capillary pericytes is independent of activation of MAPK signaling pathways.Poria cocos inhibits high glucose-induced proliferation of rat mesangial cells.Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese.Chromium and polyphenols from cinnamon improve insulin sensitivity.Maturation of arteriovenous fistula: Analysis of key factors.Serum uric acid is associated with arterial stiffness in men with newly diagnosed type 2 diabetes mellitus.‘Let Your Food Be Your Medicine’: Exotic Fruits and Vegetables as Therapeutic Components for Obesity and Other Metabolic Syndromes
P2860
Q28594461-7855CBAB-44BB-4ED9-86BD-ACB4CBC6E605Q30358451-F25E5547-E48D-45C5-8B80-80BD5EA0D80AQ33750688-521C5582-26D9-4256-BE0E-B4D3D79EDC7AQ33768652-6F0221A1-2B41-4997-8790-44E7EF22D87BQ33979747-AAAF20A7-C9F6-4A5F-A7DE-AB14D634D3E6Q34137628-7DADA115-8956-463C-8B00-FAAD87A8EF99Q34460615-8E4D81CA-DA52-4104-B983-2EEA45D47318Q34524690-97BEA50E-B739-44FB-BBA3-E115F14DD108Q35460295-657E30D8-37A4-44E2-A692-A67DB6C29816Q35631986-CC08A9C6-B396-4E71-808F-5E73AC4BD11AQ35661942-92395D2D-B3E7-46DA-BE83-FF3EE54057BCQ35870605-ED9A0230-289F-44B9-A946-4DD5A03B43FBQ35905038-86B0E690-9874-4C9B-B058-E1E1574E5DD6Q36158965-880A7C87-412E-4F04-B02C-205107739CD6Q36297823-8AA1B371-C2C0-463C-AD6D-429FF57C0CF3Q36576553-AD176BB5-BAF2-44EF-AAB2-9FFAE48ACE84Q36744879-CA06C377-4DBD-483C-AADE-9DD1E4F4031BQ36966082-5A387EF2-C00C-4114-B901-928675F40F92Q37044976-F816240C-8886-47B4-96BD-087E8A80BF6CQ38762998-496B29ED-A611-4036-B112-1C4DBECEEAFEQ38910576-9ACA7AA7-7DDD-4332-8CEC-FD773ABB2A28Q42215654-BE0709CF-BBA9-485E-9236-CFE36994A2D0Q45891523-F4DC2115-7ABC-4CFA-888B-1A7D44D30DF9Q45943326-D8489E9B-1A32-48D6-8226-B5E41C0FD9F8Q46782933-DB8F8578-F0BC-42AA-85A2-DA2511A17A23Q47142994-FE93BDB8-4775-4AD7-82E7-2614D7B6E8A1Q48875986-3EACC477-F741-4E83-B468-DE5FDCAF4B7AQ58870452-151F7461-6850-4224-8624-B4C95EF78C4E
P2860
A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A lethal tetrad in diabetes: h ...... , and endothelial dysfunction.
@ast
A lethal tetrad in diabetes: h ...... , and endothelial dysfunction.
@en
type
label
A lethal tetrad in diabetes: h ...... , and endothelial dysfunction.
@ast
A lethal tetrad in diabetes: h ...... , and endothelial dysfunction.
@en
prefLabel
A lethal tetrad in diabetes: h ...... , and endothelial dysfunction.
@ast
A lethal tetrad in diabetes: h ...... , and endothelial dysfunction.
@en
P921
P1476
A lethal tetrad in diabetes: h ...... , and endothelial dysfunction.
@en
P2093
Timothy J Lyons
Yongxin Yu
P304
P356
10.1097/00000441-200511000-00005
P407
P577
2005-11-01T00:00:00Z